Publications by authors named "Sixten Borg"

Claim this Profile
P
Performance of standardized cancer patient pathways in Sweden visualized using observational data and a state-transition model.
Sixten Borg, Ann-Sofi Hörstedt, Tobias Carlsson, Mef Nilbert, Anna-Maria Larsson

Sci Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of the measure of case discussion complexity to guide selection of prostate cancer patients for multidisciplinary team meetings.
Jessica Wihl, Victor Falini, Sixten Borg, Olof Stahl, Thomas Jiborn

Cancer Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Diabetes Questionnaire to add patients' perspectives to diabetes care for adults with type 1 and type 2 diabetes: nationwide cross-sectional study of construct validity assessing associations with generic health-related quality of life and clinical variables.
Maria Svedbo Engström, Janeth Leksell, Unn-Britt Johansson, Sixten Borg, Bo Palaszewski

BMJ Open· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life in chronic conditions using patient-reported measures and biomarkers: a DEA analysis in type 1 diabetes.
Sixten Borg, Ulf-G Gerdtham, Katarina Eeg-Olofsson, Bo Palaszewski, Soffia Gudbjörnsdottir

Health Econ Rev· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life and glycaemic control among adults with type 1 and type 2 diabetes - a nationwide cross-sectional study.
Maria Svedbo Engström, Janeth Leksell, Unn-Britt Johansson, Sixten Borg, Bo Palaszewski

Health Qual Life Outcomes· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcome and experience measures for diabetes: development of scale models, differences between patient groups and relationships with cardiovascular and diabetes complication risk factors, in a combined registry and survey study in Sweden.
Sixten Borg, Katarina Eeg-Olofsson, Bo Palaszewski, Maria Svedbo Engström, Ulf-G Gerdtham

BMJ Open· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction models for exacerbations in different COPD patient populations: comparing results of five large data sources.
Martine Hoogendoorn, Talitha L Feenstra, Melinde Boland, Andrew H Briggs, Sixten Borg

Int J Chron Obstruct Pulmon Dis· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A disease-specific questionnaire for measuring patient-reported outcomes and experiences in the Swedish National Diabetes Register: Development and evaluation of content validity, face validity, and test-retest reliability.
Maria Svedbo Engström, Janeth Leksell, Unn-Britt Johansson, Katarina Eeg-Olofsson, Sixten Borg

Patient Educ Couns· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease: Are Current Models Suitable to Evaluate Personalized Medicine?
Martine Hoogendoorn, Talitha L Feenstra, Yumi Asukai, Andrew H Briggs, Sixten Borg

Value Health· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness of pomalidomide in patients with relapsed and refractory multiple myeloma in Sweden.
Sixten Borg, Hareth Nahi, Markus Hansson, Dawn Lee, Jamie Elvidge

Acta Oncol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of ferric carboxymaltose in iron-deficient patients with chronic heart failure in Sweden.
Thomas Hofmarcher, Sixten Borg

J Med Econ· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcome measures and risk factors in a quality registry: a basis for more patient-centered diabetes care in Sweden.
Sixten Borg, Bo Palaszewski, Ulf-G Gerdtham, Odegaard Fredrik, Pontus Roos

Int J Environ Res Public Health· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness models for chronic obstructive pulmonary disease: cross-model comparison of hypothetical treatment scenarios.
Martine Hoogendoorn, Talitha L Feenstra, Yumi Asukai, Sixten Borg, Ryan N Hansen

Value Health· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A maximum likelihood estimator of a Markov model for disease activity in Crohn's disease and ulcerative colitis for annually aggregated partial observations.
Sixten Borg, Ulf Persson, Tine Jess, Ole Østergaard Thomsen, Tryggve Ljung

Med Decis Making· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors affecting chronic obstructive pulmonary disease (COPD)-related costs: a multivariate analysis of a Swedish COPD cohort.
Ulf-Göran Gerdtham, L Fredrik Andersson, Asa Ericsson, Sixten Borg, Sven-Arne Jansson

Eur J Health Econ· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost-effectiveness of treatment with erythropoietin compared to red blood cell transfusions for patients with chemotherapy induced anaemia: a Markov model.
Sixten Borg, Anna H Glenngård, Anders Osterborg, Ulf Persson

Acta Oncol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Swedish cost burden of overweight and obesity--evaluated with the PAR approach and a statistical modelling approach.
Knut Odegaard, Sixten Borg, Ulf Persson, Marianne Svensson

Int J Pediatr Obes· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective incremental cost analysis of a hospital-based COPD Disease Management Programme in Sweden.
Alf Tunsäter, Mikael Moutakis, Sixten Borg, Ulf Persson, Leif Strömberg

Health Policy· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark.
Tine Jess, Lene Riis, Ida Vind, Karen Vanessa Winther, Sixten Borg

Inflamm Bowel Dis· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden: a decision-analytic model.
Sixten Borg, Ulf Persson, Kristina Allikmets, Karin Ericsson

Clin Ther· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epoetin alfa and darbepoetin alfa for the treatment of chemotherapy-related anemia in cancer patients in Sweden: comparative analysis of drug utilization, costs, and hematologic response.
Ulf Persson, Sixten Borg, Sandra Jansson, Tor Ekman, Lars Franksson

Adv Ther· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost differences for COPD with and without physician-diagnosis.
Sven-Arne Jansson, Anne Lindberg, Asa Ericsson, Sixten Borg, Eva Rönmark

COPD· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obesity, survival, and hospital costs-findings from a screening project in Sweden.
Sixten Borg, Ulf Persson, Knut Odegaard, Göran Berglund, Jan-Ake Nilsson

Value Health· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A computer simulation model of the natural history and economic impact of chronic obstructive pulmonary disease.
Sixten Borg, Asa Ericsson, Jadwiga Wedzicha, Amund Gulsvik, Bo Lundbäck

Value Health· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of exacerbations on the asthmatic patient's preference scores.
Fredrik Andersson, Sixten Borg, Elisabeth Ståhl

J Asthma· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis